메뉴 건너뛰기




Volumn 2, Issue 10, 2007, Pages 637-639

The prevention and treatment (and cost) of cancer

(1)  Martens, Eric a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BCR ABL PROTEIN; CANCER VACCINE; IMATINIB; POLYKETIDE SYNTHASE; PROTEIN KINASE FYN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR;

EID: 35948941316     PISSN: 15548929     EISSN: None     Source Type: Journal    
DOI: 10.1021/cb7002169     Document Type: Editorial
Times cited : (1)

References (5)
  • 2
    • 0033987746 scopus 로고    scopus 로고
    • Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia
    • Druker, B. J., and Lydon, N. B. (2000) Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia, J. Clin. Invest. 105, 3-7.
    • (2000) J. Clin. Invest , vol.105 , pp. 3-7
    • Druker, B.J.1    Lydon, N.B.2
  • 4
    • 34547568170 scopus 로고    scopus 로고
    • High-throughput, microarray-based synthesis of natural product analogues via in vitro metabolic pathway construction
    • Kwon, S. J., Lee, M., Ku, B., Sherman, D. H., and Dordick, J. S. (2007) High-throughput, microarray-based synthesis of natural product analogues via in vitro metabolic pathway construction, ACS Chem. Biol. 2, 419-425.
    • (2007) ACS Chem. Biol , vol.2 , pp. 419-425
    • Kwon, S.J.1    Lee, M.2    Ku, B.3    Sherman, D.H.4    Dordick, J.S.5
  • 5
    • 35948937477 scopus 로고    scopus 로고
    • Genentech, Inc
    • Genentech, Inc., www.gene.com/gene/news/press-releases/ display.do?method=detail&id=10107.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.